EBR Systems (EBRCZ) FCF Margin (2025 - 2026)
EBR Systems (EBRCZ) posted FCF Margin of 996.66% for Q1 2026, up 43.4% sequentially from 1760.83% in Q4 2025.
EBR Systems (EBRCZ) FCF Margin (2025 - 2026) Analysis & Trends
EBR Systems has reported FCF Margin for 2 years, with the latest figure at 996.66% in Q1 2026.
- Quarterly FCF Margin changed N/A year-over-year to 996.66% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 1678.61% (changed N/A YoY) and the FY2025 annual result came in at 3517.32%, changed N/A from the prior year.
- FCF Margin rose to 996.66% in Q1 2026 per EBRCZ's latest filing, from 1760.83% in the prior quarter.
- Over five years, FCF Margin peaked at 996.66% in Q1 2026 and troughed at 7286.23% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 15.81% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 16.07% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 21.26% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 23.50% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 33.60% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 14.10% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 1.28% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 5.32% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 18.73% |
| 10 | EBR Systems | 11.82 Mn | 11.82 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -996.66% |
| Dec 31, 2025 | -1,760.83% |
| Sep 30, 2025 | -2,815.62% |
| Jun 30, 2025 | -7,286.23% |